newsfilter
← Latest News
Business Wire·

Exact Sciences Launches the Oncodetect™ Molecular Residual Disease Test

The new, highly sensitive, tumor-informed test detects up to 200 ctDNA* variants, identifying signs of colorectal cancer (CRC) recurrence up to two years earlier than imaging—making it one of the most comprehensive